GRP78 downregulation enhanced the sensitivity to chemotherapy drugs of multiple types of cancer cells and tumor endothelial cells, including head and neck, breast, lung, colon, glioma, and bladder cancers [62,85,86,87,88,89,90,91]. The gene discussed is HSPA5; the disease is central nervous system cancer.